AZD2281 in Combination With Liposomal Doxorubicin in Advanced Solid Tumours
Clinical trial NCT00819221 · TERMINATED
Trial details
- NCT number
- NCT00819221
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-05
- Primary completion
- 2011-11-30
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.